FIND (www.FINDdx.org) The Director of Access will join a discussion with HE Samia Suluhu Hassan, President of the United Republic of Tanzania and other distinguished panelists, calling on governments and decision-makers to prioritize local manufacturing capacity as a key part of your pandemic preparedness and resiliency planning; The session will take place at the World Innovation Summit for Health (WISH), which this week will bring together leading experts and decision-makers to address pressing global health challenges.
FIND, the global alliance for diagnostics, will share experiences from leadership of the diagnostics pillar of the Access to COVID-19 Tools (ACT) Accelerator (https://www.ACT-a.org/) in a distinguished panel session during the World Innovation Summit for Health (WISH) (https://2022.WISH.org.qa/), which will take place this week in Doha, Qatar.
The session, titled Bridging the Supply Chain Gap to Deliver Resilience, will take place from 1:15-2:15 p.m. AST, in Ballroom 3 at Multaqa.
Dr. Emma Hannay, Director of Access at FIND, will join a discussion with HE Samia Suluhu Hassan, President of the United Republic of Tanzania; Jean-Paul Scheuer, Regional Vice President of Sanofi; and HE Ahmad Al-Sayed, Minister of State and Chairman of the Board of Directors of the Qatar Free Zones Authority.
The uneven distribution of supply has been one of the main barriers to implementing COVID-19 testing.
Despite significant demand for global COVID-19 tests, test manufacturing capacity remains highly centralized in a few countries, contributing to complex supply chains and driving up costs.
FIND calls on governments and decision-makers to prioritize and invest in local manufacturing capacity as a key part of their pandemic preparedness, integrated into strategies to close critical gaps in the health system, particularly in the primary care.
Throughout the COVID-19 pandemic, limited local production capacity within already fragile health systems in low- and middle-income countries (LMICs) has resulted in exclusive reliance on global supply chains for diagnostic tests, and has left many health care providers without access.
Tests urgently needed (https://bit.ly/3rwOr6A).
This contributed to a wide disparity in testing rates: while high-income countries, at the end of the second quarter of 2022, performed 2.01 tests per 1,000 people each day, LMICs only achieved rates of 0.04 tests for every 1,000 people (https://bit.ly /3SZL9V1).
FIND is working with ACT-Accelerator partners to address supply chain issues, facilitating investments in local manufacturing and supporting technology transfers (https://bit.ly/3V5ihN2) from test developers.
high quality from LMIC-based manufacturers.
Manufacturers in Africa, Asia and South America have been supported to expand production capacity and enable end-to-end manufacturing.
FIND has also begun discussions with countries in the Middle East that have shown interest in supporting local manufacturing of diagnostics.
Such investments to close supply chain gaps and local manufacturing will benefit communities and health systems beyond the COVID-19 pandemic.
ACT-Accelerator partners are now developing a plan to support countries in their transition to long-term control of COVID-19, ensuring that they have equitable and sustained access to the medical countermeasures necessary to manage it.
At the same time, it will maintain a state of readiness to intensify programs and support to the countries, if and when the epidemiological situation requires it.
WISH is a global summit organized every two years by the Qatar Foundation (https://www.QF.org.qa/), bringing together leading experts and decision-makers to address pressing global health challenges.
To speak with Dr. Emma Hannay, FIND Director of Access, contact firstname.lastname@example.org